Enfermedades no transmisibles: pobreza, depresión y diabetes | 07 MAY 17

Sindemia: una nueva categoría que reúne lo social y lo biológico

El termino "sindemia" se refiere a problemas de salud sinérgicos que afectan la salud de una población en sus contextos sociales y económicos
Autor/a: Dr Emily Mendenhall, PhD; Dr Emily; Dr Emily Mendenhall, Brandon A Kohrt, MD, Prof Shane A Norris, PhD, Prof David Ndetei, MD, Prof Dorairaj Prabhakaran, MD Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations
INDICE:  1. Página 1 | 2. Página 1
Página 1
  1. Singer, M. A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA syndemic. Free Inq Creat Sociol. 1996; 24: 99–110
  2. Singer, MC. Introduction to syndemics: a systems approach to public and community health. Jossey-Bass, San Francisco; 2009
  3. Singer, MC. Aids and the health crisis of the US urban poor: the perspective of critical medical anthropology. Soc Sci Med. 1994; 39: 931–948
  4. Singer, MC, Erickson, PI, Badiane, L et al. Syndemics, sex and the city: Understanding sexually transmitted diseases in social and cultural context. Soc Sci Med. 2006; 63: 2010–2021
  5. Singer, MC and Clair, S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. 2003; 17: 423–441
  6. Singer, MC. Deperate measures: a syndemic approach to the anthropology of health in a violent city. in: B Rylko-Bauer, L Whiteford, P Farmer (Eds.) Global health in times of violence. School for Advanced Research Press, New Mexico; 2009: 137–156
  7. Mendenhall, E. Syndemic suffering: social distress, depression, and diabetes among Mexican immigrant women. Left Coast Press, Walnut Creek, CA; 2012
  8. Mendenhall, E. Beyond comorbidity: a critical perspective of syndemic depression and diabetes in cross-cultural contexts. Med Anthropol Q. 2015; 30: 462–478
  9. Omran, A. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Q. 1971; 49: 38
  10. Popkin, BM. Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr. 2006; 84: 289–298
  11. Mendenhall, E, Omondi, GB, Bosire, E et al. Stress, diabetes, and infection: syndemic suffering in an urban public hospital clinic in Kenya. Soc Sci Med. 2015; 146: 11–20
  12. Mendenhall, E. Syndemic suffering in Soweto: violence and inequality at the nexus of health transition in South Africa. Ann Anthropol Pract. 2015; 38: 302–318
  13. Patel, V, Chisholm, D, Parikh, R et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016; 387: 1672–1685
  14. Schmitz, N, Gariepy, G, Smith, KJ et al. Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes. Diabetes Care. 2014; 37: 970–978
  15. Anderson, R, Grigsby, A, Freedland, K et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002; 32: 235–247
  16. Gonzalez, JS, Peyrot, M, McCarl, LA et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008; 31: 2398–2403
  17. Gavard, J, Lustman, P, and Clouse, R. Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care. 1993; 16: 1167–1178
  18. Anderson, R, Freedland, K, Clouse, R, and Lustman, P. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 2001; 24: 1069–1078
  19. Holt, RIG, de Groot, M, and Golden, SH. Diabetes and depression. Curr Diabetes Rep. 2014; 14: 491
  20. Golden, SH, Lazo, M, Carnethon, M, and Page, P. Depressive symptoms and diabetesexamining a bidirectional association between depression and diabetes. J Am Med Assoc. 2008; 299: 2751–2759
  21. Knol, MJ, Twisk, JW, Beekman, AT, Heine, RJ, Snoek, FJ, and Pouwer, F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006; 49: 837–845
  22. Nouwen, A, Winkley, K, Twisk, J et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: A systematic review and meta-analysis. Diabetologia. 2010; 53: 2480–2486
  23. van der Feltz-Cornelis, CM, Nuyen, J, Stoop, C et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry. 2010; 32: 380–395
  24. de Groot, M, Anderson, R, Freedland, KE, Clouse, RE, and Lustman, PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001; 63: 619–630
  25. Lustman, PJ, Anderson, RJ, Freeland, KE, de Groot, M, Carney, RM, and Clouse, RE. Depression and poor glycemic control. Diabetes Care. 2000; 23: 934–942
  26. Mezuk, B, Chaikiat, Å, Li, X, Sundquist, J, Kendler, KS, and Sundquist, K. Depression, neighborhood deprivation and risk of type 2 diabetes. Health Place. 2013; 23: 63–69
  27. Musselman, DL, Betan, E, Larsen, H, and Phillips, LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry. 2003; 54: 317–329
  28. Talbot, F and Nouwen, A. A review of the relationship between depression and diabetes in adults: is there a link?. Diabetes Care. 2000; 23: 1556–1562
  29. Moulton, CD, Pickup, JC, and Ismail, K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015; 3: 461–471
  30. Kivimäki, M, Batty, G, Jokela, M et al. Antidepressant medication use and risk of hyperglycemia and diabetes mellitus: a noncausal association?. Biol Psychiatry. 2011; 70: 978–984
  31. Deuschle, M. Effects of antidepressants on glucose metabolism and diabetes mellitus type 2 in adults. Curr Opin Psychiatr. 2013; 26: 60–65
  32. Kivimaki, M, Hamer, M, Batty, G et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care. 2010; 33: 2611–2616
  33. Yoon, J, Cho, E-G, Lee, H-K, and Park, S. Antidepressant use and diabetes mellitus risk: a meta-analysis. Korean J Fam Med. 2013; 34: 228–240
  34. Barnard, K, Peveler, R, and Holt, R. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation. Syst Rev. 2013; 36: 3337–3345
  35. Wu, CS, Gau, SS, and Lai, M-S. Long-term antidepressant use and the risk of type 2 diabetes mellitus: a population-based, nested case-control study in Taiwan. J Clin Psychiatry. 2014; 75: 31–38
  36. Spielmans, G, Berman, M, Linardatos, E, Rosenlicht, N, Perry, A, and Tsai, A. Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013; 10: e1001403
  37. Gerhard, T, Akincigil, A, Correll, C, Foglio, N, Crystal, S, and Olfson, M. National trends in second-generation antipsychotic augmentation for nonpsychotic depression. J Clin Psychiatry. 2014; 75: 490–497
  38. Popkin, BM and Hawkes, C. Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol. 2016; 4: 174–186
  39. Basu, S, Stuckler, D, McKee, M, and Galea, G. Nutritional determinants of worldwide diabetes: an econometric study of food markets and diabetes prevalence in 173 countries–corrigendum. Public Health Nutr. 2012; 16: 1
  40. Vellakkal, S, Subramanian, SV, Millett, C, Basu, S, Stuckler, D, and Ebrahim, S. Socioeconomic inequalities in non-communicable diseases prevalence in India: disparities between self-reported diagnoses and standardized measures. PLoS One. 2013; 8: e68219
  41. Vellakkal, S, Millett, C, Basu, S et al. Are estimates of socioeconomic inequalities in chronic disease artefactually narrowed by self-reported measures of prevalence in low-income and middle-income countries? Findings from the WHO-SAGE survey. J Epidemiol Community Health. 2014; 69: 218–225
  42. Lee, C, Tsenkova, V, and Carr, D. Childhood trauma and metabolic syndrome in men and women. Soc Sci Med. 2012; 29: 997–1003
  43. Felitti, VJ, Anda, RF, Nordenberg, D et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) study. Am J Prev Med. 1998; 14: 245–258
  44. Danese, A, Moffitt, T, Harrington, H et al. Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. Arch Pediatr Adolesc Med. 2009; 163: 1135–1143
  45. Mendenhall, E and Jacobs, EA. Interpersonal abuse and depression among mexican immigrant women with type 2 diabetes. Cult Med Psychiatry. 2012; 36: 136–153
  46. Mendenhall, E. The ‘cost’ of healthcare: poverty, depression, and diabete among mexican immigrants in the united states. in: BA Kohrt, E Mendenhall (Eds.) Global mental health: anthropological perspectives. Left Coast Press, Walnut Creek, CA; 2015
  47. Agardh, E, Allebeck, P, Hallqvist, J, Moradi, T, and Sidorchuk, A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011; 40: 804–818
  48. Everson, SA, Maty, SC, Lynch, JW, and Kaplan, GA. Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes. J Psychosom Res. 2002; 53: 891–895
  49. Leone, T, Coast, E, Narayanan, S, and De-Graft Aikins, A. Diabetes and depression comorbidity and socio-economic status in low and middle income countries (LMICs): a mapping of the evidence. Global Health. 2012; 8: 1
  50. Mendenhall, E, Norris, SA, Shidhaye, R, and Prabhakaran, D. Depression and type 2 diabetes in low- and middle-income countries: a systematic review. Diabetes Res Clin Pract. 2014; 103: 276–285
  51. Jaspers, L, Colpani, V, Chaker, L et al. The global impact of non-communicable diseases on households and impoverishment: a systematic review. Eur J Epidemiol. 2014; 30: 163–188
  52. Beaglehole, R, Epping-Jordan, J, Patel, V et al. Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care. Lancet. 2008; 372: 940–949
  53. Saito, S, Mpofu, P, Carter, E et al. Declining tuberculosis incidence among people receiving hiv care and treatment services in east Africa, 2007–2012. J Acquir Immune Defic Syndr. 2016; 71: e96–106
  54. Bloomfield, GS, Hogan, JW, Keter, A et al. Hypertension and obesity as cardiovascular risk factors among HIV seropositive patients in Western Kenya. PLoS One. 2011; 6: e22288
  55. Ravishankar, N, Gubbins, P, Cooley, RJ et al. Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet. 2009; 373: 2113–2124
  56. Patel, V, Araya, R, Chatterjee, S et al. Treatment and prevention of mental disorders in low-income and middle-income countries. Lancet. 2007; 370: 991–1005
  57. Prince, M, Patel, V, Saxena, S et al. No health without mental health. Lancet. 2007; 370: 859–877
  58. Lund, C, Tomlinson, M, de Silva, M et al. PRIME: a programme to reduce the treatment gap for mental disorders in five low-and middle-income countries. PLoS Med. 2012; 9: e1001359
  59. Neupane, D, Panthi, B, McLachlan, CS et al. Prevalence of undiagnosed depression among persons with hypertension and associated risk factors: a cross-sectional study in urban Nepal. PLoS One. 2015; 10: e0117329
  60. Druss, BG, von Esenwein, SA, Compton, MT, Rask, KJ, Zhao, L, and Parker, RM. A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. Am J Psychiatry. 2010; 167: 151–159
  61. Popkin, BM, Adair, LS, and Ng, SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012; 70: 3–21
  62. Monteiro, CA, Moubarac, JC, Cannon, G, Ng, SW, and Popkin, B. Ultra-processed products are becoming dominant in the global food system. Obes Rev. 2013; 14: 21–28
  63. Guariguata, L, Whiting, DR, Hambleton, I, Beagley, J, Linnenkamp, U, and Shaw, JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103: 137–149
  64. Mohan, V, Sandeep, S, Deepa, R, Shah, B, and Varghese, C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res. 2007; 125: 217–230
  65. Ministry of Health and Family Welfare and Government of India. Chapter 12: HIV Prevalence. In: National Family Health Survey (NFHS-3), 2005–2006. Delhi. http://dhsprogram.com/pubs/pdf/FRIND3/FRIND3-Vol1andVol2.pdf; 2007. ((accessed Jan 24, 2017).)
  66. Oxlade, O and Murray, M. Tuberculosis and poverty: why are the poor at greater risk in India?. PLoS One. 2012; 7: 1–8
  67. Urban Health Division and Ministry of Health and Family Welfare. Health of the urban poor in India. Key results from the National Family Health survey, 2005–06. Delhi. http://dhsprogram.com/pubs/pdf/FRIND3/FRIND3-Vol1andVol2.pdf; 2007. ((accessed Jan 24, 2017).)
  68. Kessler, RC and Bromet, EJ. The epidemiology of depression across cultures. Annu Rev Public Health. 2013; 34: 119–138
  69. Poongothai, S, Pradeepa, R, Ganesan, A, and Mohan, V. Prevalence of depression in a large urban south Indian population—the Chennai urban rural epidemiology study (CURES–70). PLoS One. 2009; 4: e7185
  70. Kessler, RC, Aguilar-Gaxiola, S, Alonso, J et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc. 2011; 18: 23–33
  71. Misra, A, Pandey, RM, Devi, JR, Sharma, R, Vikram, NK, and Khanna, N. High prevalence of diabetes, obesity and dyslipidaemia in urban slum population in northern India. Int J Obes Relat Metab Disord. 2001; 25: 1722–1729
  72. IDF. IDF diabetes atlas. 7th edn. International Diabetes Federation, Brussels; 2015
  73. National AIDS and STI Control Programme. Kenya HIV estimates. http://www.unaids.org/sites/default/files/country/documents/KEN_narrative_report_2014.pdf; 2014. ((accessed Jan 24, 2017).)
  74. World Health Organization. Global tuberculosis report 2014. World Health Organization, Geneva; 2014
  75. Ndetei, DM, Khasakhala, LI, Kuria, MW, Mutiso, VN, Ongecha-Owuor, FA, and Kokonya, DA. The prevalence of mental disorders in adults in different level general medical facilities in Kenya: a cross-sectional study. Ann Gen Psychiatry. 2009; 8: 1
  76. Ayah, R, Joshi, MD, Wanjiru, R et al. A population-based survey of prevalence of diabetes and correlates in an urban slum community in Nairobi, Kenya. BMC Public Health. 2013; 13: 371
  77. Oti, SO, van de Vijver, SJ, Agyemang, C, and Kyobutungi, C. The magnitude of diabetes and its association with obesity in the slums of Nairobi, Kenya: results from a cross-sectional survey. Trop Med Int Health. 2013; 18: 1520–1530
  78. Madise, NJ, Ziraba, AK, Inungu, J et al. Are slum dwellers at heightened risk of HIV infection than other urban residents? Evidence from population-based HIV prevalence surveys in Kenya. Health Place. 2012; 18: 1144–1152
  79. Magadi, M. The disproportionate high risk of HIV infection among the urban poor in sub-Saharan Africa. AIDS Behav. 2013; 17: 1645–1654
  80. Ogaro, TD, Githui, W, Kikuvi, G et al. Diversity of Mycobacterium tuberculosis strains in Nairobi, Kenya. Afr J Health Sci. 2012; 20: 82–90
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024